What is VVOS's current stock price?

VVOS (Vivos Therapeutics, Inc.) is currently trading at $0.65 with a market cap of $3.8M.

What sector is Vivos Therapeutics, Inc. in?

Vivos Therapeutics, Inc. (VVOS) operates in the Healthcare sector, specifically in the Medical - Devices industry.

Is VVOS a good stock to buy?

Analysts have a Buy consensus on VVOS with a price target of $2.13. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

VVOS Vivos Therapeutics, Inc.

Healthcare

$0.65+6.02%ClosedMarket Cap: $3.8M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

-7.84

P/S

0.18

EV/EBITDA

-0.65

DCF Value

$-15.53

FCF Yield

-507.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

61.8%

Operating Margin

-115.5%

Net Margin

-128.4%

ROE

-2239.2%

ROA

-100.3%

ROIC

-148.6%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$5.1M	$-7.8M	$—
Q4 null	$3.8M	$-7.0M	$—
FY null	$17.4M	$-21.2M	$—
Q3 null	$6.8M	$-5.4M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$2.13

Target (Median)

$2.13

Target Range

$1.75 - $2.50

0 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell

Ascendiant CapitalBuy

2026-04-22

HC Wainwright & Co.Buy

2026-04-17

Ascendiant CapitalBuy

2025-12-03

Ascendiant CapitalBuy

2025-09-09

Trading Activity

Insider Trades

View All

V-Co Investors 3 LLC10 percent owner

SellFri Apr 10

V-Co Investors 3 LLC10 percent owner

SellFri Apr 10

V-Co Investors 3 LLC10 percent owner

SellFri Apr 10

Skaff Michael C10 percent owner

BuyThu Apr 02

Skaff Michael C10 percent owner

BuyThu Apr 02

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

Exchange

—

Beta

6.21

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.

Peers

ADGM

AEMD

ALUR

AMS

ANL